Abstract

Ketoprofen 10% in Pluronic Lecithin Organogel

Author(s): Allen Loyd V Jr

Issue: Mar/Apr 2019 - Volume 23, Number 2

Page(s): 150

Download in electronic PDF format for $75
  • Ketoprofen 10% in Pluronic Lecithin Organogel Page 1

Abstract

A formulation for preparing Ketoprofen 10% in Pluronic Lecithin Organogel. Includes ingredients, method of preparation, discussion, and references for the compounding pharmacist.

Related Keywords

  • ketoprofen
  • formulation
  • nonsteroidal anti-inflammatory drug
  • NSAID
  • inflammation
  • inflammatory disorders
  • analgesic
  • analgesia
  • pain relief
  • topical preparations

Related Categories

  • FORMULATIONS
  • PAIN MANAGEMENT
  • ALLERGY/IMMUNOLOGY/INFLAMMATION
  • DOSAGE FORMS/DRUG CARRIERS

Printer-Friendly Version

Related Articles from IJPC

Issue/Page
View/Buy		 Title/Author
(Click for Abstract / Details / Purchase)
Mar/Apr 2004
Pg. 101-105
Pluronic Lecithin Organogel for Local Delivery of Anti-Inflammatory Drugs
Author(s): Frankum James, Ramsay Dale, Das Nandita G, Das Sudip K
Mar/Apr 2019
Pg. 150
Ketoprofen 10% in Pluronic Lecithin Organogel
Author(s): Allen Loyd V Jr
Jan/Feb 2019
Pg. 52
Ketoprofen 10% in Pluronic Lecithin Organogel
Author(s): Allen Loyd V Jr
Nov/Dec 2010
Pg. 513
Baclofen 5%, Capcaicin 0.075%, Ketoprofen 10%, and Tetracaine 2% in Pluronic Lecithin Organogel
Author(s): Allen Loyd V Jr
Nov/Dec 2010
Pg. 514
Baclofen 5%, Gabapentin 5%, Ketoprofen 10%, and Lidocaine 5% in Pluronic Lecithin Organogel
Author(s): Allen Loyd V Jr
May/Jun 2011
Pg. 245
Ketoprofen 10%, Ibuprofen 10%, Cyclobenzaprine Hydrochloride 2%, and Piroxicam 2% in Pluronic Lecithin Organogel Gel
Author(s): Allen Loyd V Jr
May/Jun 2010
Pg. 182-192
Compounded Analgesic Therapy for Disorders of Movement: Arthritis, Neuropathic Pain, and Postpolio Syndrome
Author(s): Brown Scott, Erickson Brian, Muller George, Bryant-Snure Susan J, Mestayer Richard F III
Nov/Dec 2010
Pg. 512
Amitriptyline Hydrochloride 2%, Baclofen 5%, Ketamine Hydrochloride 5%, Ketoprofen 10% in Pluronic Lecithin Organogel
Author(s): Allen Loyd V Jr
May/Jun 2010
Pg. 204-206
Managing Pain with Transdermal Ketoprofen
Author(s): Williams KaCee D
May/Jun 2014
Pg. 256-261
Preparation and In Vitro Evaluation of a Pluronic Lecithin Organogel Containing Ricinoleic Acid for Transdermal Delivery
Author(s): Boddu Sai HS, Bonam Sindhu Prabha, Wei Yangjie, Alexander Kenneth
Nov/Dec 1999
Pg. 496-500
Enhancement of Skin Penetration of Nonsteroidal Anti-Inflammatory Drugs from Extemporaneously Compounded Topical-Gel Formulations
Author(s): Goodwin Donald A, Fuhram L Clifton
Mar/Apr 2011
Pg. 157
Amitriptyline Hydrochloride 2%, Carbamazepine 2%, Gabapentin 10%, and Ketoprofen 2% Transdermal Gel
Author(s): Allen Loyd V Jr
Mar/Apr 2024
Pg. 131
Amitriptyline Hydrochloride 2%, Carbamazepine 2%, Gabapentin 10%, and Ketoprofen 2% Transdermal Gel
Author(s): Allen Loyd V Jr
Sep/Oct 2008
Pg. 452
Ketoprofen 20% Topical Solution
Author(s): Allen Loyd V Jr
Jul/Aug 2018
Pg. 319
Ketoprofen 10% in Pluronic Lecithin Organogel
Author(s): Allen Loyd V Jr
Nov/Dec 2010
Pg. 520
Ketoprofen 5% and Lidocaine Hydrochloride 0.5% Topical Gel
Author(s): Allen Loyd V Jr
Jul/Aug 2014
Pg. 278-286
Compounded Pain Formulations: What is the Evidence?
Author(s): Asbill Scott, Sweitzer Sarah M, Spigener Shuler, Romero-Sandoval Alfonso
Mar/Apr 2016
Pg. 155-158
Utilization of Compounded Medications in an Oral Medicine Practice
Author(s): Stock Shannon, Rubino Katie, Woo Sook-Bon, Margolis Arthur, Thomas Irena, Aboalela Ali, Treister Nathaniel
Mar/Apr 2024
Pg. 100-109
Compounded Pain Formulations: What is the Evidence?
Author(s): Asbill Scott, Sweitzer Sarah M, Spigener Shuler, Romero-Sandoval Alfonso
Nov/Dec 2008
Pg. 543
Indomethacin 2% in Pluronic Lecithin Organogel
Author(s): Allen Loyd V Jr